Assura Plc (LON:AGR – Get Free Report) insider Jayne Cottam acquired 363 shares of the business’s stock in a transaction on Wednesday, March 5th. The shares were bought at an average cost of GBX 41 ($0.53) per share, with a total value of £148.83 ($192.31).
Jayne Cottam also recently made the following trade(s):
- On Wednesday, February 5th, Jayne Cottam acquired 405 shares of Assura stock. The shares were bought at an average cost of GBX 37 ($0.48) per share, with a total value of £149.85 ($193.63).
Assura Trading Up 1.0 %
Shares of AGR opened at GBX 40.74 ($0.53) on Friday. The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84. Assura Plc has a 1 year low of GBX 35.24 ($0.46) and a 1 year high of GBX 46.20 ($0.60). The company has a 50 day simple moving average of GBX 38.69 and a two-hundred day simple moving average of GBX 39.77. The firm has a market cap of £1.33 billion, a P/E ratio of -38.94, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37.
Assura Company Profile
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
Featured Stories
- Five stocks we like better than Assura
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- What Are Trending Stocks? Trending Stocks Explained
- 3 Stocks to Buy While Others Stay on the Sidelines
- What does consumer price index measure?
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.